Focus of the study: safety of XFB19

Clinical trials for Focus of the study: safety of XFB19 explained in plain language.

Never miss a new study

Get alerted when new Focus of the study: safety of XFB19 trials appear

Sign up with your email to follow new studies for Focus of the study: safety of XFB19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug XFB19 enters first human safety trial

Knowledge-focused Recruiting now

This study is the first time the drug XFB19 is being tested in humans. It aims to check if XFB19 is safe and how the body processes it. Forty healthy adults aged 18 to 55 will receive either XFB19 or a placebo. The trial is run by Xfibra, Inc. and is currently recruiting.

Matched conditions: FOCUS OF THE STUDY: SAFETY OF XFB19

Phase 1 • Sponsor: Xfibra, Inc. • Aim: Knowledge-focused

Last updated Jun 27, 2026 12:28 UTC

Focus of the study: safety of XFB19

Get alerted when new Focus of the study: safety of XFB19 trials appear

New drug XFB19 enters first human safety trial